Skip to content
Comparisons

LunaRx vs. Nurx: GLP-1 Telehealth Compared

A side-by-side of pricing, access, and clinical support between LunaRx and Nurx.

9 min readWritten and fact-checked against the sources below
Laptop, fruit bowl, and a white pharmacy bag on a kitchen table

Disclosure

The GLP Journal is published by LunaRx, so this comparison is written with that conflict disclosed. We aim for accuracy, not advocacy. Compounded GLP-1s are prepared by licensed 503A and 503B compounding pharmacies. This is not medical advice.

LunaRx and Nurx both offer GLP-1 weight care through telehealth, but they are aimed at different things. Nurx is an app-first consumer service known for convenient, accessible care; LunaRx is a focused, physician-directed program built around one outcome — losing fat while protecting muscle, with a structured plan to come off. Here is the honest side-by-side.

Both connect you with a licensed provider and, if appropriate, a compounded GLP-1 from a licensed pharmacy. The differences show up in the care model, what is included in the protocol, how pricing works, and whether there is a plan for the end.

LunaRx vs Nurx at a glance
LunaRxNurx
FocusRecomposition — lose fat, keep muscleAccessible consumer telehealth, weight included
Care modelPhysician-directed, plan calibrated to youApp-first consumer telehealth
MedicationsSemaglutide or tirzepatideGLP-1 options vary by state and availability
Muscle protectionMuscle-protective peptides built into the stackNot a stated focus
Coming-off planStructured off-ramp / taper, central to the modelNot emphasized
PricingFlat, dose-independent — $139/mo semaglutide, $149/mo tirzepatideMonthly; varies — check current pricing
If not approved$0 — you only pay if a physician approvesCheck current policy
LanguagesEnglish and Spanish, intake to taperPrimarily English
SupplyCompounded, via licensed 503A and 503B pharmaciesCompounded and/or brand, varies

How the care models differ

Nurx is built for accessible, app-first convenience — straightforward online care that is easy to start. LunaRx is built for depth in a single lane: metabolic recomposition. A licensed physician reviews your intake and calibrates a plan to you, and the same clinical thread runs from your first assessment through your taper.

If ease of entry is your priority, convenience is the draw. If you want a plan titrated to your physiology with the end in mind, depth is the draw.

What is actually in the protocol

A standard GLP-1 program prescribes the medication and titrates the dose. LunaRx pairs the GLP-1 with muscle-protective peptides and recovery support, because a real share of the weight lost on a GLP-1 alone can be lean muscle. The aim is that what you lose is fat and what stays is strength — recomposition, not just a smaller number.

Pricing: what you will actually pay

LunaRx uses flat, dose-independent pricing — $139/month for semaglutide and $149/month for tirzepatide as of 2026 — so your cost does not climb as you titrate up. A low entry price elsewhere can rise as your dose increases, so compare the total monthly cost at your expected dose, including shipping and any fees, and confirm current pricing on each service's own page.

The coming-off question

Most platforms are built around the refill. LunaRx is built around the exit: a structured taper paired with GI-recovery and metabolic-reset support, so you can come off without the rebound that tends to follow an abrupt stop. If getting off cleanly matters to you, it is central to the LunaRx model.

Where Nurx may fit better

If your priority is a simple, accessible entry point and you want to start quickly with a familiar consumer service, Nurx is a reasonable option. Confirm the GLP-1 product you would receive and the total cost at your expected dose before deciding.

Who LunaRx is for

  • You want to keep your muscle, not just lose weight.
  • You want a physician-directed plan calibrated to you.
  • You want a real plan to come off — a taper, not an open-ended subscription.
  • You want flat pricing that will not rise as your dose does.
  • You want care in English or Spanish.

Want this handled for you?

LunaRx — clinician-led GLP-1 care with a plan to come off

LunaRx connects you with a licensed clinician for an online evaluation. Depending on your state that is a live or a store-and-forward visit. If the clinician determines a GLP-1 is appropriate for you, a licensed pharmacy dispenses it — with a plan to come off when you’re ready. The prescribing decision is the clinician’s alone, and approval is not guaranteed.

Start the 2-minute eligibility checkIndependent site · by LunaRx · not medical advice

What to verify with LunaRx and Nurx

  • Is this a compounded or a branded product? If compounded, which licensed 503A or 503B pharmacy prepares it, and is it properly licensed? Compounding compliance rests with the dispensing pharmacy.
  • Total monthly cost at your expected dose, including shipping and any fees.
  • Whether muscle-protective support is included or extra.
  • What happens to your plan and price if you stop.

Common questions about LunaRx vs Nurx

What is the main difference between LunaRx and Nurx?
LunaRx is a focused, physician-directed recomposition program — a GLP-1 paired with muscle-protective peptides and a structured off-ramp. Nurx is an app-first consumer service positioned around accessible, convenient care.
Which is cheaper, LunaRx or Nurx?
It depends on your dose. LunaRx uses flat pricing — $139/month for semaglutide and $149/month for tirzepatide as of 2026 — that does not rise as you titrate up. A low entry price elsewhere can increase with dose, so compare the total monthly cost at your expected dose and confirm current pricing on each site.
Do LunaRx and Nurx sell compounded GLP-1s?
LunaRx dispenses compounded GLP-1s via licensed 503A and 503B compounding pharmacies. Nurx offers compounded and/or brand depending on the state. Confirm which product you would receive and which licensed pharmacy fills it.
Does either help you keep muscle?
LunaRx builds muscle-protective peptides into the protocol to reduce lean-mass loss during weight loss. A standard GLP-1 program typically prescribes the medication alone, so ask whether muscle support is included.
Does either help you come off the medication?
LunaRx makes a structured taper central to the model. Coming-off support is not a stated emphasis of most consumer services, so ask what the plan is for the end.
How do I get started with LunaRx?
Complete a short online eligibility check in English or Spanish. A licensed physician reviews it and approves or denies treatment. You are only charged if you are approved.

Bottom line

Nurx is accessible and convenient; LunaRx is a focused, physician-directed recomposition program with muscle-protective peptides, flat pricing, and a built-in off-ramp. If a simple entry point is your priority, Nurx fits. If you want to lose fat, keep muscle, and come off on a plan, that is what LunaRx is built for. We disclose that we publish this comparison — verify pricing and fit for your situation.

Sources

Primary sources for the claims in this article. Trial results are reported as published; prescribing information is the authoritative reference for dosing and safety.

  1. 1.
    FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize

    U.S. Food and Drug Administration · 2025

    Shortages resolved (tirzepatide December 2024, semaglutide February 2025) and the compounding enforcement deadlines that followed.

  2. 2.
    Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A

    U.S. Food and Drug Administration, guidance for industry · 2018

    A 503A pharmacy may not compound, regularly or in inordinate amounts, a drug that is essentially a copy of a commercially available product. Patient-specific compounding remains possible where the prescriber documents a clinically significant difference for that patient.

  3. 3.
    FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List

    U.S. Food and Drug Administration · 2026

    April 2026 proposal to exclude these molecules from the 503B bulk drug substances list.

Get the weekly research update

New trials, FDA moves, and pricing shifts — one plain-English email a week. No spam.

Unsubscribe anytime. Read our privacy policy.

Related in Comparisons